WEDNESDAY 12TH OF OCTOBER, 20.00-21.00 CEST
You are cordially invited to join our virtual E-Seminar endorsed by VAS.
Treatment strategies for thoracic central venous obstruction
Introduction by moderator Tobias Steinke
Hybdrid graft-catheter devices - James Gilbert
Venous recanalisation and stenting - Maarten Snoeijs
Afterwards 30 minutes of discussion
Panellists: Adam Farkas and Gurkan Sengolge
The webinar will take place on Wednesday, 12th of October 2022 at 20.00-21.00 CEST
11 am PDT (Pacific Daylight Time)
2 pm EST (Eastern Daylight Time)
8 pm CEST (Central European Summer Time)
3 am JST (Japan Standard Time)
9 pm IDT (Israel Daylight Time)
Have you missed the latest E-Seminar?
The VAS E-Seminars 2022 are sponsored by
Bold thinking. Bolder actions. We are Medtronic.
We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.
In everything we do, we are engineering the extraordinary.
Gore engineers medical devices that treat a range of cardiovascular and other health conditions. With more than 50 million medical devices implanted over the course of more than 45 years, Gore builds on its legacy of improving patient outcomes through research, education and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Resource options in occluded central trunks